LOWE SYNDROME

Clinical trials for LOWE SYNDROME explained in plain language.

Never miss a new study

Get alerted when new LOWE SYNDROME trials appear

Sign up with your email to follow new studies for LOWE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Promising drug aims to slow kidney damage in rare lowe syndrome

Disease control Not yet recruiting

This early study tests a drug called piclidenoson in 5 adult men with Lowe syndrome, a rare genetic disorder that harms the kidneys. The goal is to see if the drug can improve how the kidneys reabsorb important small proteins over 6 months. Researchers will also check safety and …

Matched conditions: LOWE SYNDROME

Phase: PHASE2 • Sponsor: Can-Fite BioPharma • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

LOWE SYNDROME

Get alerted when new LOWE SYNDROME trials appear

Promising drug aims to slow kidney damage in rare lowe syndrome